chains from strain C58 and the other Lyt-3.1 strains of mice, which they have termed Ef-2 (8) . They propose that this difference involves a single VK group.
Previous work in our laboratories has enabled us to define a set of reagents detecting an idiotype on the BALB/e 2,4-dinitrophenyl (DNP)-binding myeloma protein MOPC 460 (Id-460) (9, 10) that is inherited by strains of mice that carry the Ig-H complex derived from BALB/c mice (11) . Id-460 is expressed during conventional anti-DNP antibody responses in vivo. In these experiments, a different set of reagents has been prepared that define a related Id-460 determinant. We have determined the time-course of expression of Id-460 during primary and secondary in vivo anti-DNP antibody responses. In this paper, we demonstrate that the expression of Id-460 during in vivo anti-DNP antibody responses is controlled by genes mapping in VH. We further demonstrate that VK genes present in strains BALB/c and AKR, but missing or unexpressed in strain C58, are required for the expression of Id-460. This is the first Id to clearly differentiate the VK repertoire of strains C58 and AKR.
Materials and Methods
Mice. Mice of strains BALB/eByJ and B10.D2/oSn were purchased from The Jackson Laboratory, Bar Harbor, Maine. The major histocompatibility complex (MHC)-congenic strains BALB.B (H-2 b) and BALB.K (H-2 k) were provided by Donal Murphy from the Comprehensive Cancer Center, Yale University, New Haven, Conn. Strain C.B20 was obtained from Litton Bionetics under contract to Michael Potter (National Cancer Institute [NCI] contract NO I-CB-92142) and strains BAB-14 and B.C9 were gifts of Roy Riblet and Mel Bosma at the Institue for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pa.; these Ig-congenic strains were maintained at Yale from stock provided. Strains BALB/C58-Lyt-2a,3 a (C.C58) and BALB/AKR-Lyt-2a,3 a (C.AKR) were bred at the Massachusetts Institute of Technology, Cambridge, Mass. by introgressively backcrossing the Lyt-3.1 marker onto BALB/cAnN mice (12) . The generations of backcrossing and inbreeding of .these mice was N19F3 for C.C58 and N18F3 for C.AKR. Mice of both strains bear the Lyt-3 a allele and the V~ IB peptide marker associated with this allele in the parental strains. The (CBA/N × BALB/c)F1 male mice bred from CBA/N maintained at Yale and BALB/cByJ express the Xlinked immune deficiency (Xid) found in CBA/N mice whereas the reciprocal (BALB/c × CBA/N)F1 male mice are phenotypically normal.
Myleoma Proteins. MOPC 460, MOPC 31C, FLOPC 21, and MOPC 104E plasmacytomas along with proteins XRPC-25 and TEPC-15 were obtained from Michael Potter (Litton Bionetics under NCI contract NO1-CB-92142). The plasmacytomas were carried in BALB/ cByJ mice as ascites tumors. Ascites fluid was precipitated in 45% saturated ammonium sulfate at 4°C. MOPC 460 and MOPC 315 proteins were purified by affinity chromatography using DNP-lysyl-glycine-Sepharose (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.). MOPC 31C and FLOPC 21 were further purified by DEAE-ion-exchange chromatography. MOPC 104E was purified on Sephacryl S-300 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.). MOPC 511 protein was a gift from Rose Liebermann, National Institutes of Health (NIH) and affinity-purified HOPC-8 was a gift from Stuart Rudikoff (NIH). G-1 is a monoclonal antibody from BALB/c mice; it binds both DNP and phosphorylcholine (P. Gearhart. Unpublished observations.).
Anti-ld Antisera. Anti-Id-460 antiserum was produced by immunization of New Zealand White rabbits with 500/~g MOPC 460 (M460) emulsified in complete Freund's adjuvant and given intraperitoneally. Rabbits were blocked for production of antibody to the 315 Id by intravenous injection of 20 mg MOPC 315 (M315) protein immediately before immunization. 3 wk after primary immunization, the rabbits were boosted with 500 pg of M460 protein in incomplete Freund's adjuvant intraperitoneally. Again, rabbits received 20 mg of M315 protein intravenously. A further boost of 2 mg of an alum precipitate of M460 protein was given 16 d later as three successive intravenous injections. After immunization, rabbits were bled at 2-wk intervals by cardiac puncture. Antibodies specific for Id-460 were detected by Ouchterlony C-ENET1C CONTROIJ OF EXPRESSION OF IDIOTYPE ld-460 double-diffusion analysis using M315, HOPC-8, and MOPC 511 proteins and normal mouse serum for comparison. Purification of rabbit antibodies directed against the hapten-binding site of the Id-460 was by a modification of the procedure of Claflin and Davie (13) . To remove shared public specificities, 6 ml of antiserum was passed through a 10-ml column of M315-Sepharose. The excluded volume of this column was then absorbed to a 10-ml column of M460-Sepharose equilibrated in phosphate-buffered saline (PBS). After a wash of five times the column volume with PBS, elution of antibody directed to the hapten-binding site of M460 was performed with 6 ml of 0.05 M DNP-L-glycine in PBS. The DNP eluate was collected and dialyzed exhaustively against PBS. Antibody yields averaged ~300 p,g/ml serum. The purified anti-Id-460 Id antibody was stored in PBS at -20°C.
Antigens and Immunization of Mice. Ovalbumin (OVA), bovine serum albumin (BSA) and their DNP-conjugates, DNPs-OVA and DNP2s-BSA, were prepared as previously described (14) .
Mice were immunized by injecting 2 × 109 Bordetella pertussis organisms intraperitoneally followed by 100/tg of an alum precipitate of DNPs-OVA (14) . A boosting immunization of 10 p,g DNPs-OVA (in PBS-D or as an alum precipitate) was given intraperitoneally 21 d later. These mice were bled from the orbital plexus at the time of immunization and at various days after both the primary injection and the boost. Individual serum samples were stored at -20°C until assayed.
Radioimmunoassays. Id-460.
The radioimmunoassay used to quantitate Id-460 in mouse serum was a modification of the solid-phase tube assay of Askenase and Leonard (15) . In a typical experiment, 50 p,I of rabbit anti-Id-460 antibody (20 pg/ml) in PBS was used to coat individual wells of flexible polyvinyl microtiter plates. The plates were incubated overnight at 4°C. After recovery of the anti-Id-460 antibody, the plates were washed with PBS and coated with 200 p,I of 1% BSA for 30 min at room temperature. After three further washes with PBS, 50 pl of dilutions of test serum or M460 standard was added to each well along with 10 ~1 of mSI-M460 (6,000 cpm/well). The plates were incubated overnight at 4°C, and then washed six times with distilled water. Individual wells were cut, and the counts per minute 125I bound were counted in a gamma counter. The concentration of Id-460 for each serum sample was determined by plotting the percent 125I-M460 bound versus the various dilutions of the serum sample. The reciprocal of the serum dilution giving 50% inhibition of binding of the I25I-M460 was then multiplied by the concentration of M460 standard giving 50% inhibition of ~25I-M460 to yield the concentration of Id-460 in the serum. Background counts were < 1%. Table I shows the specificity of this assay for various myeloma proteins. This assay does not yield parallel lines for the M460 as compared to serum Id-460 material (11) . Thus, the values given for serum Id- 460 levels can not be taken as absolute. Nevertheless, all the lines obtained using serum Id-460 are parallel, and thus our distinction of high-and low-producer strains is clearly valid. Furthermore, the fact that immunization with DNP leads to dramatic changes in Id-460 levels, coupled with our finding that the induced Id-460 is all removed by passage of serum over DNP-lysyl-Sepharose (data not shown), provide strong support for our contention that Id-460 is produced by certain strains as a component of their anti-DNP antibody response.
Anti-DNP. Anti-DNP antibody concentration was also determined by solid-phase radioimmunoassay. Flexible polyvinyl microtiter plates were coated with 10/zg DNP26-BSA/well (16) . The plates were washed with PBS, and then blocked using 1% BSA. Serum samples at various 125 dilutions were added to each well and allowed to react with DNP and washed. I-antl-mouse Fab (10,000 cpm/well) was allowed to react with bound antibody overnight at 4°C. The concentration of anti-DNP antibody for each serum sample was determined by plotting the percent x25I-anti-mouse Fab bound versus the various dilutions of the serum sample. The reciprocal of the serum dilution giving 50% binding of x2SI-anti-mouse Fab was th0¢l multiplied by the concentration of anti-DNP standard at 50% binding of 125I-anti-mouse Fab. Standard anti-DNP antibody was affinity purified from a pool of mouse anti-DNP by passage over DNPlysyl-Sepharose.
Results
The Effect of VII Genes on the Expression of ld-460. To determine the effect of genes in the Ig-H complex on the expression of Id-460, mice of various inbred and Igcongenic strains were immunized with DNPs-OVA. They were bled at intervals, boosted, and again bled multiple times. The serum was tested for content of Id-460 and total anti-DNP antibody in radioimmunoassay. A typical result of this study is shown in Fig. 1 A. A summary of the results is presented in Table II . It is clear that there are low levels of Id-460 in all strains reacting in our radioimmunoassay; similar material is found also in normal mouse serum. However, if one examines the amount of Id-460 found in secondary anti-DNP responses, high-and low-producer strains can be discriminated. Strains that produce high levels of Id-460 include BALB/c and BAB-14, whereas strains giving low levels include C.B20 and B10.D2. All of these mice make substantial amounts of anti-DNP antibody (>1 mg/ml). The low response in strain C.B20 that has the genetic background of BALB/c and that bears the Ig-H complex of C57BL/6 (Ig b) demonstrates linkage of a gene required for Id-460 expression to the Ig-H complex. The high response in strain BAB-14, which bears CH genes from C57BL/6 and VH genes derived mainly from strain BALB/c, strongly suggests that a gene(s) required for high levels of Id-460 expression is located in VH. Further studies using a variety of strains have shown that high levels of Id-460 correlate with possession of VH genes derived from BALB/c and low levels of expression with VH derived from C57BL/6 (Table II) . However, one exception to this rule is seen; strain C58 does not express high levels of Id-460 even though it possesses the VH genes derived from BALB/c.
The Effect of Vt¢ Genes on the Expression of ld-460. Strain C58 was originally included
to determine the possible contribution of VK genes to the expression of Id-460. The failure of C58 mice to make Id-460 could have been interpreted in several ways. To clearly test the involvement of V~¢ genes in the expression of Id-460, C.C58 and C.AKR congenic mice--which bear V~¢ genes from strains C58 and AKR, respectively, on a BALB/c genetic background--were tested. These mice were prepared using the Lyt-3.1 gene product as a selecting marker (12) . That they express the K-chain markers of AKR and C58 associated with Lyt-3.1 was confirmed by determining IB peptide, Ef-1 a, and Ef-2 marker expression in these mice (W. 
The Effect of Xid Genes on Id-460 Expression.
The immune defective mouse strain CBA/N, which carries the Xid gene, and the FI male progeny of (CBA/N X BALB/e) matings do not express the VH-linked Id associated with the phosphorylcholine-binding BALB/c myeloma protein TEPC 15, whereas the F1 female progeny express normal levels of this Id (17) . Reciprocal F1 male offspring of CBA/N and BALB/c parental strains were immunized with DNPs-OVA to determine if the expression of Id-460 was controlled or affected by the Xid gene. The results are given in Fig. 1 D. Although it is apparent that the nondefective F~ males make more Id-460 than do their defective FI male counterparts, the differences are at most twofold, and both sets of mice make very high levels of Id-460. Thus, the Xid gene does not preclude Id-460 expression in this response. 
Discussion
In these studies, we have examined the effect upon the expression of Id-460 of four different gene complexes that are known to control the quantity or quality of antibody responses. We have succeeded in mapping at least two genes required for Id-460 expression to VH and to VK. We have also shown that MHC-linked genes and the Xid gene have little effect on Id-460 expression.
Most Id that have been studied demonstrate linkage to VH genes. Thus, the linkage of Id-460 to VH conforms to expectations for an inherited Id (1). Furthermore, after the discovery ofVK polymorphisms, linkage of Id to VK genes has also been shown for some Id (2). However, Id-460 is the first Id to distinguish between VK genes in strains C58 and AKR. A recent publication by Gibson and MacLean (8) has defined a marker (Ef2) that distinguishes VK genes of C58 from those of AKR and BALB/c. The Ef2 marker appears to define a VK group. More recently, Gibson et al. 2 have shown that K-chains from BALB/c myeloma proteins that focus at this position belong to the VK1 group, as does the M460 K-chain. Thus, the finding that Id-460 expression correlates with Ef2 is supported by amino acid sequence datafl The finding of involvement of VK genes in Id-460 is further strengthened by the failure of the G-1 monoclonal antibody to inhibit our anti-Id-460 assay. This rnonoclonal antibody binds to DNP and has a' VH sequence identical to that of M460 as far as has been determined (45 residues), except at position 31 (P. Gearhart. Personal communication.), but has a h-light chain.
The lack of effect of the Xid gene on the expression of Id-460 is of interest because this gene greatly influences the expression of the T15 Id. It has also been said to control the expression of other Id (R. Woodland. Personal communication.). It is of interest to us because it is our belief that the finding of high levels of Id-460 shortly after boosting in the secondary response reflects the activity of a unique set of helper T cells required for optimal production of anti-DNP antibody early in the response (18, 19) . In other systems, this helper T cell would appear to operate by selecting particular sets of B cells for activation by means of an anti-idiotypic receptor (20) (21) (22) . Because Id-460 appears to be the dominant Id in the response to DNP-OVA expressed early in the secondary response, 2 and because careful analysis of the functioning of this specialized set of helper T cells in CBA/N mice for the anti-DNP antibody response has not detected any abnormalities (23) , the finding of normal expression of Id-460 would be expected. In the T15 system, failure to express the T15 idiotype in (CBA/N × BALB/c)F1 males is correlated with the absence of the Id-recognizing helper T cell set for the T15 idiotype (20) . Further analysis of helper T cells for the Id-460 response would be expected to confirm their presence in (CBA/N × BALB/c)F1 male mice. These studies can not resolve the question of whether the genes we have mapped to VH and VI¢ are structural or regulatory genes. The linkage of VK genetic markers to Lyt-3 had suggested a possible regulatory effect of this locus on x-chain expression, and this was of interest because Lyt-3 is expressed on suppressor T cells but not on helper T cells (24) . However, gene mapping data have shown that the structural genes for VK are indeed on chromosome 6 (25) . Furthermore, our results show that Id-460 expression is not controlled by Lyt-3 itself, because mice carrying Lyt-3.1 derived from strain AKR express the Id, whereas mice that carry Lyt-3.1 derived from strain C58 do not express the Id. The data of Gibson et al. (26) strongly support the structural nature of this genetic difference, although activity of an unidentified regulatory gene linked to the structural gene still can not be excluded.
It is clear from other work that Id-460 expression is strongly regulated, 2 and this can be seen in the dramatic fluctuations observed during the course of an antibody response to DNP-OVA (Fig. 1) . Subsequent experiments will focus on the time-course of expression of Id-460 at the antibody-forming-cell level, with particular attention on the regulation of Id within particular isotypes. 2 The cellular basis of this regulation is now being studied.
Summary
The genetic control of the expression of an idiotype (Id-460) associated with the 2,4-dinitrophenyl (DNP)-binding BALB/c myeloma protein MOPC 460 was studied using congenic strains of mice. It was shown that the expression of high levels of Id-460 during secondary in vivo anti-DNP-ovalbumin responses was determined by genes governing immunoglobulin heavy-chain variable and r-light chain variable regions (Vr). Appropriate alleles at both loci were required for the expression of Id-460. Genes in the major histocompatibility complex and the X-linked immune deficiency gene found in strain CBA/N did not greatly affect Id-460 expression. The VK gene controlling Id-460 expression can be differentiated from Lyt-3, and it is the first instance in which expression of an idiotype subdivides the VK genes associated with the Lyt-3 a allele. Although it islikely that the VK gene(s) involved are structural, the involvement of a regulatory gene linked to the structural gene can not be excluded.
